NCT03187249

Brief Summary

Anxiety and depression have negative effect on outcomes of chronic obstructive pulmonary disease (COPD). Intervention strategy including behavioral-cognitive therapy and pulmonary rehabilitation are promising in improving life quality, disease symptom and outcomes. But there's not standard algorithm in China so far. The study aims to compare the effectiveness of these interventions and develop an intervention algorithm of anxiety and depression in COPD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 14, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

June 15, 2017

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

June 14, 2017

Status Verified

June 1, 2017

Enrollment Period

3.5 years

First QC Date

June 13, 2017

Last Update Submit

June 13, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hospital Anxiety and Depression Scale

    total score

    12 weeks

Secondary Outcomes (3)

  • moderate and severe COPD exacerbations

    3 years

  • modified British medical research council score

    3 years

  • COPD assessment test score

    3 years

Study Arms (4)

Cognitive Behavioral Therapy

EXPERIMENTAL

receive cognitive-behavioral therapy for 12 weeks

Behavioral: Cognitive Behavioral Therapy

Pulmonary Rehabilitation Therapy

EXPERIMENTAL

receive pulmonary rehabilitation therapy for 12 weeks

Behavioral: Pulmonary Rehabilitation Therapy

Combined Therapy

EXPERIMENTAL

receive both cognitive-behavioral therapy and pulmonary rehabilitation therapy for 12 weeks

Behavioral: Combined Therapy

Regular Therapy

NO INTERVENTION

receive regular therapy for chronic obstructive pulmonary disease

Interventions

12 weeks cognitive-behavioral lessons, once a week

Cognitive Behavioral Therapy

12 weeks pulmonary rehabilitation exercise

Pulmonary Rehabilitation Therapy

cognitive-behavioral lessons and pulmonary rehabilitation exercise for 12 weeks

Combined Therapy

Eligibility Criteria

AgeUp to 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Stable COPD patients with mild or moderate anxiety and depression

You may not qualify if:

  • Patients with bronchial asthma or other severe pulmonary diseases or having received pulmonary surgery in 6 months
  • Patients with tumor history during past 5 years
  • Patients with COPD exacerbations during past 4 weeks
  • Participants in clinical trials
  • Patients in pregnancy or breastfeeding
  • Patients unable to complete questionaire independently
  • Patients older than 80 years old
  • Patients receiving long-term domiciliary oxygen therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, 100032, China

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveAnxiety DisordersDepression

Interventions

Cognitive Behavioral TherapyPsychotherapy, Multiple

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Central Study Contacts

Jiangna Han, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Pulmonary Vascular Disease Center

Study Record Dates

First Submitted

June 13, 2017

First Posted

June 14, 2017

Study Start

June 15, 2017

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

June 14, 2017

Record last verified: 2017-06

Locations